CINECA IRIS Institutional Research Information System

TORREGROSSA, LIBORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.024
EU - Europa 2.835
AS - Asia 1.310
AF - Africa 249
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 9.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.951
IT - Italia 1.033
CN - Cina 689
SE - Svezia 525
DE - Germania 436
SG - Singapore 347
AT - Austria 269
BG - Bulgaria 195
CI - Costa d'Avorio 157
GB - Regno Unito 154
TR - Turchia 90
VN - Vietnam 79
SN - Senegal 72
CA - Canada 69
FI - Finlandia 56
RU - Federazione Russa 55
IN - India 45
HK - Hong Kong 26
NG - Nigeria 20
NL - Olanda 20
FR - Francia 15
UA - Ucraina 14
BE - Belgio 12
CZ - Repubblica Ceca 12
BR - Brasile 11
IR - Iran 10
PL - Polonia 9
CH - Svizzera 8
EU - Europa 6
KR - Corea 6
AU - Australia 5
EC - Ecuador 4
GR - Grecia 4
LT - Lituania 4
CY - Cipro 3
ES - Italia 3
IE - Irlanda 3
PK - Pakistan 3
TW - Taiwan 3
IL - Israele 2
JP - Giappone 2
SV - El Salvador 2
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KZ - Kazakistan 1
MN - Mongolia 1
MT - Malta 1
MX - Messico 1
NP - Nepal 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.446
Salva come PNG Salva come JPEG
Città #
Chandler 613
Fairfield 548
Santa Clara 503
Woodbridge 364
Ashburn 305
Shanghai 268
Houston 265
Seattle 257
Vienna 244
Milan 237
Ann Arbor 218
Sofia 195
Wilmington 192
Cambridge 191
New York 188
Singapore 176
Abidjan 157
Pisa 125
Serra 119
Boardman 118
Beijing 116
Princeton 113
Florence 98
Lawrence 92
Medford 80
Dakar 72
Ottawa 58
Frankfurt am Main 53
London 53
San Diego 51
Istanbul 45
Rome 38
Bremen 36
Nanjing 33
Dong Ket 31
Izmir 31
Des Moines 28
Vicopisano 28
Ogden 27
Hong Kong 25
Cascina 24
Redmond 23
Boulder 20
Helsinki 20
Lagos 20
Los Angeles 20
Fuzhou 18
Hyderabad 16
Dearborn 15
Quanzhou 15
Norwalk 14
Lancaster 13
Munich 13
Hefei 12
Washington 12
Brussels 11
Guangzhou 11
Jacksonville 11
Brno 10
Kent 10
Nanchang 10
Redwood City 10
Shenyang 10
Changsha 9
Marseille 9
Genoa 8
Hebei 8
Livorno 8
Naples 8
Jiaxing 7
Kunming 7
Phoenix 7
Wuhan 7
Bologna 6
Haikou 6
Lappeenranta 6
Lucca 6
Tianjin 6
Zhengzhou 6
Chengdu 5
Dallas 5
Hangzhou 5
Montreal 5
Pontedera 5
Saint Louis 5
Samsun 5
Urmia 5
Xiamen 5
Zurich 5
Amsterdam 4
Casale Monferrato 4
Jinan 4
Kocaeli 4
Moncalieri 4
Ningbo 4
Povo 4
Pune 4
Turin 4
Xi'an 4
Atakum 3
Totale 6.936
Salva come PNG Salva come JPEG
Nome #
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 197
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 173
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 171
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 164
null 160
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 158
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 156
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 156
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 145
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 144
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 134
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 133
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 127
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 124
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 123
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 123
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 122
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 122
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 121
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 117
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 117
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 115
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 115
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 115
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 113
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 113
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 113
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 109
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 109
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 109
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 107
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 107
A large functioning parathyroid lipoadenoma 104
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 103
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 102
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. 102
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 102
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 101
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 100
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 99
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 97
CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1 97
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 96
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 96
High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience 95
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 94
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 92
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 92
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 92
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 91
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease 89
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 87
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements 85
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis 84
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 84
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 82
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 81
COVID-19 autopsy cases: detection of virus in endocrine tissues 79
Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies 77
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 77
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 77
null 77
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma 76
Hippo pathway affects survival of cancer patients: Extensive analysis of TCGA data and review of literature 75
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 75
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 74
Galectin-3 is highly expressed in nonencapsutated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothetial cell 1 immunoreactivity 72
null 71
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 71
Impact of energy-based devices in pediatric thyroid surgery 71
null 70
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 70
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 70
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 70
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 69
null 68
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 67
Correlation of the presurgical diagnosis of follicular variant of papillary thyroid cancer with the disease status after 10 years of follow-up. 65
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 65
Fine-needle aspiration cytology and histological types of thyroid cancer in the elderly: Evaluation of 9070 patients from a single referral centre 65
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4) 64
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 64
Follicular (FVPTC) VS Classical (CVPTC) variant of papillary thyroid cancer: correlation of the outcome after 12 years of follow up. 61
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 60
Firm mass in thyroid of an elderly patient: Not always cancer 59
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 59
CDC73/HRPT2 mutations and parafibromin immunohistochemistry in a large series of sporadic parathyroid carcinomas and atypical adenomas 56
Atypical parathyroid adenomas: Challenging lesions in the differential diagnosis of endocrine tumors 55
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 54
Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs 54
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 51
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 51
Molecular genetics of follicular-derived thyroid cancer 49
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 48
Molecular alterations in relation to histopathological characteristics in a large series of pediatric papillary thyroid carcinoma from a single institution 44
The macrofollicular variant of papillary thyroid cancer (MF-PTC): a bicentric retrospective analysis of 65 cases. 41
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 40
Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma 39
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 38
Higher RET gene expression levels do not represent an alternative RET activation mechanism in medullary thyroid carcinoma 38
Totale 9.235
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020742 0 0 0 0 0 0 161 118 139 117 170 37
2020/2021744 63 37 43 31 47 74 67 57 82 63 77 103
2021/20221.149 27 23 41 47 186 218 50 42 68 60 99 288
2022/20232.222 211 326 186 187 234 237 29 177 446 11 145 33
2023/20241.396 111 119 180 157 163 249 71 35 28 39 106 138
2024/20251.523 46 138 60 251 434 443 151 0 0 0 0 0
Totale 9.738